Answer
No. Both components are targeted monoclonal antibodies, although the licensed uses commonly require chemotherapy as part of the treatment plan.
Sources for this answer
- Phesgo 600 mg/600 mg, 1200 mg/600 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.